For acne
Strong evidenceA meta-analysis of 3 randomized, double-blind, vehicle-controlled trials in 629 patients aged 11 to 49 found tretinoin microsphere gel 0.04% significantly reduced both inflammatory and noninflammatory lesions over 12 weeks versus vehicle. Tretinoin is a first-line acne treatment in major dermatology guidelines, with consistent results across formulations from 0.025% to 0.1%.
Multiple randomized controlled trials or a meta-analysis support this use. The effect is real and repeatable.
- Tretinoin microsphere gel in facial acne vulgaris: a meta-analysis (Journal of Drugs in Dermatology, 2008; meta-analysis)